<DOC>
	<DOCNO>NCT02855112</DOCNO>
	<brief_summary>Spinal Muscular Atrophy ( SMA ) autosomal recessive disease motor neuron . In early 1980s , Werdnig Vienna University Hoffman Heidelberg University describe disorder . So SMA type 1 name Werdnig- Hoffman disease . This first genetic disorder cause death cystic fibrosis infant prevalence 1 6000 birth . Mutation SMN1 gene ( Survival Motor Neuron ) reason disease cause decrease SMN protein production . So alpha motor neuron spinal cord ventricle horn destroy cause progressive paralysis defenite death.No specific therapy yet available treatment Werdnig-Hoffmann disease . Treatment disease-modifying supportive . SMA type 1 diagnose within early 6 month birth accompany breath disorder definite death 2 year . The affected infant weak muscle tone could n't even hold head . Perhaps open way patient application stem cell could deliver trophic factor apoptotic cell . So study focus effectivness cell therapy via adipose derive mesenchymal stem cell probable phenotypic change patient .</brief_summary>
	<brief_title>Allogeneic Adipose Derived Stem Cells Werdnig Hoffman Patients</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Muscular Atrophy , Spinal</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<mesh_term>Spinal Muscular Atrophies Childhood</mesh_term>
	<criteria>Age 12 month , Weak muscle tone , Weakness mobility , Patients sit without full conduction nerve Existence home sens , Normal Brain function Age beyound 12 month , Brain abnormality , Loss sensory function Malignancies</criteria>
	<gender>All</gender>
	<minimum_age>5 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>